Company: CYTK
Filing Date: 2025-09-22
Form Type: 8-K
Source: 0001193125-25-209437
Chunk: 6

Company: CYTOKINETICS INC
Filing Date: 2025-09-22
Form: 8-K
Item: Item 1.01
Chunk 6
---
, and the Company does not undertake to update the statements included in this Current Report on Form8-Kfor subsequent developments, except as may be required by law.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit Number      Description                                                                                                                                      
             4.1      Indenture, dated as of September 19, 2025, between Cytokinetics, Incorporated and U. S. Bank Trust Company, National Association, as trustee.    
            99.1      Press Release issued by the Company on September 16, 2025.                                                                                       
            99.2      Press Release issued by the Company on September 16, 2025.                                                                                       
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
             4.2      Form of Note, representing the Company’s 1.75% Convertible Senior Notes due 2031 (included as Exhibit A to the Indenture filed as Exhibit 4.1).  
             104      Cover page interactive data file (embedded within the inline XBRL document).